These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
225 related items for PubMed ID: 9066602
1. Luminal epithelial antigen (LEA.135) expression correlates with tumor progression for transitional carcinoma of the bladder. Jones HL, Delahunt B, Bethwaite PB, Thornton A. Anticancer Res; 1997; 17(1B):685-7. PubMed ID: 9066602 [Abstract] [Full Text] [Related]
2. Luminal epithelial antigen (LEA.135) expression in adenocarcinoma of the colon. Miles SE, Kenwright DN, Gaskell DJ, Christie RM, Thornton A, Delahunt B. Anticancer Res; 1999; 19(1A):597-600. PubMed ID: 10226604 [Abstract] [Full Text] [Related]
3. [Immunohistochemical localization of epithelial membrane antigen, carcinoembryonic antigen and secretory component in urinary bladder cancer]. Takashi M, Murase T, Mitsuya H, Koshikawa T, Nagura H, Haimoto H. Hinyokika Kiyo; 1986 Apr; 32(4):541-52. PubMed ID: 2426931 [Abstract] [Full Text] [Related]
4. [Studies on multiple mucosal biopsy in patients with bladder cancer. 4. Evaluation of Thomsen-Friedenreich antigen in multiple mucosal biopsy and transitional cell carcinoma of the bladder]. Igawa M. Hinyokika Kiyo; 1986 Nov; 32(11):1663-76. PubMed ID: 3825815 [Abstract] [Full Text] [Related]
5. p53 expression compared with other prognostic factors in OMS grade-I stage-Ta transitional cell carcinoma of the bladder. Casetta G, Gontero P, Russo R, Pacchioni D, Tizzani A. Eur Urol; 1997 Nov; 32(2):229-36. PubMed ID: 9286659 [Abstract] [Full Text] [Related]
6. [Monoclonal antibodies against transitional cell carcinoma assay tumor associated antigens in different grades bladder cancer patients]. Zhang H, Zhao Z, Sun H. Zhonghua Wai Ke Za Zhi; 1996 Sep; 34(9):560-2. PubMed ID: 9594163 [Abstract] [Full Text] [Related]
7. Polyclonal Ki-67 expression in transitional cell carcinoma of the bladder. Jones HL, Delahunt B, Bethwaite PB, Thornton A. Pathology; 1997 Feb; 29(1):84-7. PubMed ID: 9094186 [Abstract] [Full Text] [Related]
8. Expression of CD44s and CD44v6 in transitional cell carcinomas of the urinary bladder: comparison with tumour grade, proliferative activity and p53 immunoreactivity of tumour cells. Kuncová J, Urban M, Mandys V. APMIS; 2007 Nov; 115(11):1194-205. PubMed ID: 18092951 [Abstract] [Full Text] [Related]
9. Prognostic significance of p53, bcl-2 and Ki-67 in high risk superficial bladder cancer. Stavropoulos NE, Filiadis I, Ioachim E, Hastazeris K, Tsimaris I, Kalogeras D, Stefanaki S, Agnantis NJ. Anticancer Res; 2002 Nov; 22(6B):3759-64. PubMed ID: 12552989 [Abstract] [Full Text] [Related]
10. Human bladder cancer associated antigens: evaluation of antigenicity in TCC tissues of different grades and in normal urothelium. Ben-Aïssa H, Paulie S, Gustafsson B, Håkansson L, Lagerkvist M, Gustafson H, Ahlstrand C, Perlmann P. Anticancer Res; 1988 Nov; 8(3):443-9. PubMed ID: 3389746 [Abstract] [Full Text] [Related]
11. P16 immunoreactivity is an independent predictor of tumor progression in minimally invasive urothelial bladder carcinoma. Krüger S, Mahnken A, Kausch I, Feller AC. Eur Urol; 2005 Apr; 47(4):463-7. PubMed ID: 15774242 [Abstract] [Full Text] [Related]
12. Immunohistochemical evaluation of nonspecific cross reactive antigen and carcinoembryonic antigen (CEA) in urinary bladder carcinoma. Asamoto M, Fukushima S, Tatemoto Y, Yamada K, Yuba R, Mori M. Anticancer Res; 1989 Apr; 9(2):319-26. PubMed ID: 2751258 [Abstract] [Full Text] [Related]
13. Identification of a cell-surface antigen (LEA.135) associated with favorable prognosis in human breast cancer. Imam SA, Esteban EF, Chen RS, Cardiff RD, Taylor CR. Cancer Res; 1993 Jul 15; 53(14):3233-6. PubMed ID: 7686814 [Abstract] [Full Text] [Related]
14. Cyclin D1 expression in transitional cell carcinoma of the bladder: correlation with p53, waf1, pRb and Ki67. Tut VM, Braithwaite KL, Angus B, Neal DE, Lunec J, Mellon JK. Br J Cancer; 2001 Jan 15; 84(2):270-5. PubMed ID: 11161387 [Abstract] [Full Text] [Related]
15. Prostate stem cell antigen predicts tumour recurrence in superficial transitional cell carcinoma of the urinary bladder. Elsamman E, Fukumori T, Kasai T, Nakatsuji H, Nishitani MA, Toida K, Ali N, Kanayama HO. BJU Int; 2006 Jun 15; 97(6):1202-7. PubMed ID: 16686711 [Abstract] [Full Text] [Related]
16. Bilharzial related, organ confined, muscle invasive bladder cancer: prognostic value of apoptosis markers, proliferation markers, p53, E-cadherin, epidermal growth factor receptor and c-erbB-2. Haitel A, Posch B, El-Baz M, Mokhtar AA, Susani M, Ghoneim MA, Marberger M. J Urol; 2001 May 15; 165(5):1481-7. PubMed ID: 11342901 [Abstract] [Full Text] [Related]
17. [Immunohistochemical study of p53 and Ki-67 antigen expression in bladder carcinoma]. Yuge F, Hirakata H, Igarashi H, Kodama M, Kawata N, Takimoto Y. Hinyokika Kiyo; 1999 Jul 15; 45(7):453-6. PubMed ID: 10466059 [Abstract] [Full Text] [Related]
18. Alteration of the vascular endothelial growth factor and angiopoietins-1 and -2 pathways in transitional cell carcinomas of the urinary bladder associated with tumor progression. Quentin T, Schlott T, Korabiowska M, Käthei N, Zöller G, Glaser F, Kunze E. Anticancer Res; 2004 Jul 15; 24(5A):2745-56. PubMed ID: 15517881 [Abstract] [Full Text] [Related]
19. E-cadherin immunoreactivity correlates with recurrence and progression of minimally invasive transitional cell carcinomas of the urinary bladder. Mahnken A, Kausch I, Feller AC, Krüger S. Oncol Rep; 2005 Oct 15; 14(4):1065-70. PubMed ID: 16142373 [Abstract] [Full Text] [Related]
20. Role of polysomy 17 in transitional cell carcinoma of the bladder: immunohistochemical study of HER2/neu expression and fish analysis of c-erbB-2 gene and chromosome 17. Simonetti S, Russo R, Ciancia G, Altieri V, De Rosa G, Insabato L. Int J Surg Pathol; 2009 Jun 15; 17(3):198-205. PubMed ID: 19443884 [Abstract] [Full Text] [Related] Page: [Next] [New Search]